Predictors of mortality in Middle East respiratory syndrome (MERS)

被引:153
作者
Hong, Ki-Ho [1 ]
Choi, Jae-Phil [2 ]
Hong, Seon-Hui [3 ]
Lee, Jeewon [3 ]
Kwon, Ji-Soo [3 ,4 ]
Kim, Sun-Mi [4 ]
Park, Se Yoon [4 ]
Rhee, Ji-Young [5 ]
Kim, Baek-Nam [6 ]
Choi, Hee Jung [7 ]
Shin, Eui-Cheol [3 ,8 ]
Pai, Hyunjoo [9 ]
Park, Su-Hyung [3 ,8 ]
Kim, Sung-Han [4 ]
机构
[1] Seoul Med Ctr, Dept Lab Med, Seoul, South Korea
[2] Seoul Med Ctr, Dept Internal Med, Seoul, South Korea
[3] Korea Adv Inst Sci & Technol, Biomed Sci & Engn Interdisciplinary Program, Daejeon, South Korea
[4] Univ Ulsan, Dept Infect Dis, Asan Med Ctr, Coll Med, 388-1 Pungnap Dong, Seoul 05505, South Korea
[5] Dankook Univ Hosp, Div Infect Dis, Dept Internal Med, Cheonan, South Korea
[6] Inje Univ, Dept Internal Med, Sanggye Paik Hosp, Seoul, South Korea
[7] Ewha Womans Univ Hosp, Dept Internal Med, Seoul, South Korea
[8] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea
[9] Han Yang Univ Hosp, Dept Internal Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
viral infection; respiratory infection; infection control;
D O I
10.1136/thoraxjnl-2016-209313
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We evaluated the clinical characteristics, cytokine/chemokine concentrations, viral shedding and antibody kinetics in 30 patients with Middle East respiratory syndrome (MERS), including 6 non-survivors admitted to 3 MERS-designated hospitals. Old age, low albumin, altered mentality and high pneumonia severity index score at admission were risk factors for mortality. In addition, severe signs of inflammation at initial presentation (at hospital days 1-4), such as high inducible protein-10 (p=0.0013), monocyte chemoattractant protein-1 (p=0.0007) and interleukin 6 (p=0.0007) concentrations, and poor viral control (high viral load at hospital days 5-10, p<0.001) without adequate antibody titres (low antibody titre at hospital days 11-16, p=0.07) during the course of disease, were associated with mortality.
引用
收藏
页码:286 / 289
页数:4
相关论文
共 7 条
[1]   Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside? [J].
Faure, Emmanuel ;
Poissy, Julien ;
Goffard, Anne ;
Fournier, Clement ;
Kipnis, Eric ;
Titecat, Marie ;
Bortolotti, Perinne ;
Martinez, Laura ;
Dubucquoi, Sylvain ;
Dessein, Rodrigue ;
Gosset, Philippe ;
Mathieu, Daniel ;
Guery, Benoit .
PLOS ONE, 2014, 9 (02)
[2]   An interferon-γ-related cytokine storm in SARS patients [J].
Huang, KJ ;
Su, IJ ;
Theron, M ;
Wu, YC ;
Lai, SK ;
Liu, CC ;
Lei, HY .
JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (02) :185-194
[3]   Severe acute respiratory syndrome vs. the Middle East respiratory syndrome [J].
Hui, David S. ;
Memish, Ziad A. ;
Zumla, Alimuddin .
CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (03) :233-241
[4]   Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome [J].
Jiang, Y ;
Xu, J ;
Zhou, CZ ;
Wu, ZG ;
Zhong, SQ ;
Liu, JH ;
Luo, W ;
Chen, T ;
Qin, QH ;
Deng, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) :850-857
[5]   Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus [J].
Kumar, Mia ;
Mazur, Steven ;
Ork, Britini L. ;
Postnikova, Elena ;
Hensley, Lisa E. ;
Jahrling, Peter B. ;
Johnson, Reed ;
Holbrook, Michael R. .
JOURNAL OF VIROLOGICAL METHODS, 2015, 223 :13-18
[6]   Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity [J].
Min, Chan-Ki ;
Cheon, Shinhye ;
Ha, Na-Young ;
Sohn, Kyung Mok ;
Kim, Yuri ;
Aigerim, Abdimadiyeva ;
Shin, Hyun Mu ;
Choi, Ji-Yeob ;
Inn, Kyung-Soo ;
Kim, Jin-Hwan ;
Moon, Jae Young ;
Choi, Myung-Sik ;
Cho, Nam-Hyuk ;
Kim, Yeon-Sook .
SCIENTIFIC REPORTS, 2016, 6
[7]   Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome [J].
Wong, CK ;
Lam, CWK ;
Wu, AKL ;
Ip, WK ;
Lee, NLS ;
Chan, IHS ;
Lit, LCW ;
Hui, DSC ;
Chan, MHM ;
Chung, SSC ;
Sung, JJY .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (01) :95-103